Nuclear Laser Medicine is a leading Italian company specializing in the development, production, and distribution of in vitro diagnostic (IVD) solutions.

Founded 40 years ago, NLM has built a strong reputation for technological innovation, precision, and quality in the field of laboratory diagnostics.

Our comprehensive portfolio includes products for infectious diseases, genetics, oncology, and HLA testing, complemented by automatized platforms and advanced digital tools designed to enhance laboratory efficiency. Certified under ISO 9001 and ISO 13485, NLM operates according to the highest international standards to ensure the safety, reliability, and performance of every solution we deliver. Headquartered in Settala (Milan, Italy), we serve customers globally through a dedicated network of partners and provide comprehensive technical and customer support.

At NLM, we are committed to driving innovation in diagnostics and contributing to the advancement of precision medicine and better health outcomes worldwide.

Nuclear Laser Medicine S.r.l. è certificata ISO 9001:2015 e
ISO 13485:2016.

Nuclear Laser Medicine partecipa annualmente ai
Controlli Esterni di Qualità (CEQ) UK NEQAS per
HCV e CF Network per fibrosi cistica.